Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
Table 5
Comparisons of adverse events between the ATB (-) and ATB (+) groups.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Comparisons of adverse events between the ATB (-) and ATB (+) groups.